Startups
Doro Mind
Albany, New York, United States
Doro Mind Inc. is a private Delaware public-benefit company offering a technology-enabled care and family-support platform for people affected by schizophrenia, psychosis and related serious mental illnesses. Co-founders and co-CEOs Mimi Liu and Brady Richards combine healthcare software experience with lived family experience; the current published clinical-provider team is led by Founding Clinical Director Robert Laitman and Associate Clinical Director Hannah Bock. Doro Care provides access to specialized clinical treatment alongside family guidance, while Doro Compass supports navigation, coordination and existing care teams. The company’s legal terms distinguish its support platform from licensed provider services; named clinicians are recorded as published clinical-provider team members without asserting payroll employment. Its neuroscience and AI relevance includes an NIH/NIDA-funded research project developing coordinated-specialty-care interfaces and large-language-model role-play to help families prepare for clinical appointments. That project is feasibility-stage research, not proof that an AI treatment is clinically effective. Current website recovery and hospitalization percentages are company-reported promotional metrics, not independently established results. SEC filings identify exact Doro Mind Inc., CIK2008487, incorporated2023, with USD2,765,000 equity sold disclosedJanuary2024 and USD4,674,990 sold disclosedMarch2026; primary sources do not name priced-round stages or all buyers. An actual USD398,580 NIDA SBIR award in2026 is recorded separately from equity. Coalition Operators, SignalFire and City Light publish Doro as a portfolio company; those sources do not allocate checks to the two specific offerings. Akin Mental Health, incorporated2021 by Stephanie Greer and Matthew Montañez, later joined Doro; its earlier funding and team are not automatically Doro’s founding or cash history. Greer’s Doro product role is preserved historically because the issuer’s2026 farewell confirms her departure.
Founded 2023
Team
Brady RichardsCo-Founder and Co-CEO |
 Clare JibbNurse Practitioner (published clinical-provider team) |
 Hannah BockAssociate Clinical Director (published clinical-provider team) |
 John MackenzieNurse Practitioner (published clinical-provider team) |
Mimi LiuCo-Founder and Co-CEO |
 Robert LaitmanFounding Clinical Director (published clinical-provider team) |
 Shayna FeuerNurse Practitioner (published clinical-provider team) |
 Sooah ChoDirector (2026 SEC filing; external investor affiliation) |
 Stephanie GreerFormer Director of Product Management (2024 issuer biography; departed by2026) |